Tags

Type your tag names separated by a space and hit enter

Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Anticancer Res. 2014 Dec; 34(12):7097-110.AR

Abstract

Tanshinone IIA (Tan-IIA) is extracted from Danshen (Salviae miltiorrhizae radix). It possesses antitumor activity against a variety of human cancer cells and its induction of apoptosis and inhibition of proliferation of gastric cancer cells are well-documented. However, the molecular mechanisms by which Tan-IIA inhibits gastric cancer have not been well-elucidated. In the present study, we evaluated the cytotoxicity of Tan-IIA against human gastric cancer AGS cells by the (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) MTT assay. The protein expression of tumor necrosis factor-alpha (TNF-α), FAS, p53, p21, cyclin A, cyclin B1, extracellular-related kinase (ERK), phospho extracellular-related kinase (p-ERK), p38, p-p38, Jun-amino-terminal kinase (JNK), phospho Jun-amino-terminal kinase (p-JNK) and β-actin in AGS cells were measured by western blotting. The cell-cycle distribution was analyzed by flow cytometry. The results showed that Tan-IIA inhibited AGS cells with time- and dose-dependent manners. AGS cells treated with Tan-IIA up-regulated the protein expression of TNFα, FAS, p-p38, p-JNK, p53, p21, caspase-3 and caspase-8 but reduced that of p-ERK, CDC2, cyclin A, and cyclin B1. The results also showed that Tan-IIA dose dependently induced G2/M phase arrest. These findings demonstrate that Tan-IIA can inhibit AGS human gastric cancer cells; one of the molecular mechanisms may be through increasing the protein expression of p-p38 and p-JNK, but decreasing that of p-ERK to induce the activation of p53, followed by increasing the protein expression of p21 to down-regulate CDC2 and cyclin B1 expression which then induces G2/M phase arrest. Another route may be through increasing the protein expression of TNF-α, FAS, caspase-8 and caspase-3 to induce apoptosis.

Authors+Show Affiliations

Tumor Research Center of Integrative Medicine, Changhua Christian Hospital, Changhua, Taiwan, ROC Comprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua, Taiwan, ROC Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan, ROC School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan, R.O.C. succ.maeva@msa.hinet.net.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25503137

Citation

Su, Chin-Cheng. "Tanshinone IIA Inhibits Gastric Carcinoma AGS Cells Through Increasing P-p38, p-JNK and P53 but Reducing p-ERK, CDC2 and Cyclin B1 Expression." Anticancer Research, vol. 34, no. 12, 2014, pp. 7097-110.
Su CC. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression. Anticancer Res. 2014;34(12):7097-110.
Su, C. C. (2014). Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression. Anticancer Research, 34(12), 7097-110.
Su CC. Tanshinone IIA Inhibits Gastric Carcinoma AGS Cells Through Increasing P-p38, p-JNK and P53 but Reducing p-ERK, CDC2 and Cyclin B1 Expression. Anticancer Res. 2014;34(12):7097-110. PubMed PMID: 25503137.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression. A1 - Su,Chin-Cheng, PY - 2014/12/16/entrez PY - 2014/12/17/pubmed PY - 2015/3/25/medline KW - G2/M arrest KW - MAPK KW - Tanshinone IIA KW - gastric carcinoma AGS cells SP - 7097 EP - 110 JF - Anticancer research JO - Anticancer Res VL - 34 IS - 12 N2 - Tanshinone IIA (Tan-IIA) is extracted from Danshen (Salviae miltiorrhizae radix). It possesses antitumor activity against a variety of human cancer cells and its induction of apoptosis and inhibition of proliferation of gastric cancer cells are well-documented. However, the molecular mechanisms by which Tan-IIA inhibits gastric cancer have not been well-elucidated. In the present study, we evaluated the cytotoxicity of Tan-IIA against human gastric cancer AGS cells by the (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) MTT assay. The protein expression of tumor necrosis factor-alpha (TNF-α), FAS, p53, p21, cyclin A, cyclin B1, extracellular-related kinase (ERK), phospho extracellular-related kinase (p-ERK), p38, p-p38, Jun-amino-terminal kinase (JNK), phospho Jun-amino-terminal kinase (p-JNK) and β-actin in AGS cells were measured by western blotting. The cell-cycle distribution was analyzed by flow cytometry. The results showed that Tan-IIA inhibited AGS cells with time- and dose-dependent manners. AGS cells treated with Tan-IIA up-regulated the protein expression of TNFα, FAS, p-p38, p-JNK, p53, p21, caspase-3 and caspase-8 but reduced that of p-ERK, CDC2, cyclin A, and cyclin B1. The results also showed that Tan-IIA dose dependently induced G2/M phase arrest. These findings demonstrate that Tan-IIA can inhibit AGS human gastric cancer cells; one of the molecular mechanisms may be through increasing the protein expression of p-p38 and p-JNK, but decreasing that of p-ERK to induce the activation of p53, followed by increasing the protein expression of p21 to down-regulate CDC2 and cyclin B1 expression which then induces G2/M phase arrest. Another route may be through increasing the protein expression of TNF-α, FAS, caspase-8 and caspase-3 to induce apoptosis. SN - 1791-7530 UR - https://www.unboundmedicine.com/medline/citation/25503137/Tanshinone_IIA_inhibits_gastric_carcinoma_AGS_cells_through_increasing_p_p38_p_JNK_and_p53_but_reducing_p_ERK_CDC2_and_cyclin_B1_expression_ L2 - http://ar.iiarjournals.org/cgi/pmidlookup?view=long&pmid=25503137 DB - PRIME DP - Unbound Medicine ER -